As evidence shown, FGF21 is reported to prevent fatty liver formation and insulin resistance in obese mice model and numerous studies showed FGF21 analogue reduced fat mass and alleviated hyperglycaemia, insulin resistance, dyslipidaemia in NASH [13, 14]. The gene discussed is FGF21; the disease is inherited lipid metabolism disorder.